• The full-service CRO

    The CRO of choice
    by the leading Investigators

    and Sites

    Serving clients ranging
    from Big Pharma

    to Start-ups

    Combining Global Coverage with true Local Expertise

    In the United States, Europe, Russia and Asia, since 2001

    Continue to the website
    Download brochure

Endometriosis safety follow-up study in Ukraine

Global Clinical Trials launches new gynecology study in Ukraine. The project is sponsored by young EU biopharma company focused on research in women’s health.

It is a multicenter, open-label, single-arm Phase III study in 160 patients suffering from endometriosis. The study will be conducted at up to 13 sites in Ukraine.

November 12, 2020

GCT enhances European presence through a strategic acquisition in Baltic States

Global Clinical Trials announces the acquisition of a long-time collaborator Larrey Ltd. GCT will now offer in-house regulatory affairs, clinical monitoring, site and project management, IMP and clinical trial materials logistics and other support in Estonia, Latvia, and Lithuania.

November 11, 2020

GCT announces expansion to the country of Georgia

Yesterday Global Clinical Trials, LLC announced the launch of full-service clinical operations in Georgia by opening a new office in Tbilisi. Having successfully conducted clinical trials there, we are now pleased to announce this new corporate milestone.

November 2, 2020

First Patient In Acute Infection Clinical Trial In Russia

Despite the COVID-19 challenging the routine of clinical trials worldwide, Global Clinical Trials has successfully randomized the first patient into a clinical trial evaluating the efficacy of IP in the sore throat pain relief.

This is a phase IV, multicenter, randomized, non-inferiority trial aiming to enroll over 300 patients globally. The first patient was enrolled only 4 days after the site activation.

October 8, 2020

Database Locked for the Rare Disease Pediatric Study

GCT team is proud for taking part in achievement of the major milestone for the Phase III clinical trial.

The study is being successfully conducted, amidst the present difficult global environment, in pediatric patients suffering from a rare neurological disease. In January 2020, GCT has successfully completed the enrollment of patients in Russia. We have now reached the next milestone – the Database Lock.

September 7, 2020

Multiple Sclerosis Observational Study in Georgia

Global Clinical Trials is managing its first local project in Georgia. It is a recently awarded observational Phase IV clinical trial in Multiple Sclerosis.

GCT team is performing local management of the multinational study sponsored by an international Big Pharma. It includes trainings, regulatory documentation handling, adjustment and submission of amendments, site monitoring and close-out, and the eTMF maintenance.

September 1, 2020

Meet our clients

All trademarks, brand names and logotypes are intellectual property of their respective owners.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2020 Global Clinical Trials, LLC

All rights reserved.